Previous 10 | Next 10 |
Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors PR Newswire First-in-class Phase 1 data presented at ESMO for ubamatamab (REGN4018; MUC16xCD3) in recurrent ovarian cancer and REGN5093 (METxMET) in MET-altered adva...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the exception of energy and utilities, all sectors of the S&P 500 are in the red for the year. Of the losing sectors, healthcare stocks have held up relatively well , outperformed only by consumer staples. Thi...
Regeneron Pharmaceuticals Inc ( NASDAQ: REGN ) is now back to near its year-to-date high but a Morgan Stanley analyst says the stock is not done pleasing its investors yet. Regeneron stock has another 20% upside On Friday, Matthew Harrison upgraded the biotech name to ...
Regeneron Announces Investor Call and Webcast at ESMO 2022 PR Newswire TARRYTOWN, N.Y. , Sept. 9, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will host a conference call and simultaneous webcast to share updates on the company's on...
Morgan Stanley and Jefferies upgraded Regeneron ( NASDAQ: REGN ) after the company reported that its best-selling eye medication, Eylea, at a higher dose, achieved noninferiority to the standard regimen in two pivotal trials. Morgan Stanley analyst Matthew Harrison opi...
Sanofi ( NASDAQ: SNY ) and Regeneron Pharmaceuticals ( NASDAQ: REGN ) on Sept. 8 reported detailed results from a phase 3 trial showing that Dupixent significantly reduced itch and skin lesions at 24 weeks in in adults with uncontrolled prurigo nodularis (P...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Regeneron Pharmaceuticals, Inc. (REGN) 2022 Wells Fargo Healthcare Conference September 08, 2022, 11:00 AM ET Company Participants Ryan Crowe - Head, IR Robert Landry - CFO Conference Call Participants Mohit Bansal - Wells Fargo Presentation ...
Shares of the large-cap biotech Regeneron Pharmaceuticals (NASDAQ: REGN) were up by a healthy 19.2% on exceptionally heavy volume as of 1:46 p.m. ET Thursday afternoon. The drugmaker has thus gained over $12 billion in market capitalization through the first half of Thursday's t...
Rivian Automotive ( RIVN ) represented one of Wall Street's notable gainers in Thursday's midday trading. Shares of the electric vehicle maker rose on word of a key partnership. Snap ( SNAP ) was another intraday standout, climbing on signs that the social media giant's CEO has ...
News, Short Squeeze, Breakout and More Instantly...
Regeneron Pharmaceuticals Inc. Company Name:
REGN Stock Symbol:
NASDAQ Market:
Regeneron Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...
2024-07-12 11:00:05 ET Trung Huynh from UBS issued a price target of $1,250.00 for REGN on 2024-07-12 10:18:00. The adjusted price target was set to $1,250.00. At the time of the announcement, REGN was trading at $1092.3075. The overall price target consensus is at $902....
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 3.6% to $0.2493 on volume of 118,503,418 shares Qualigen Therapeutics Inc. (QLGN) rose 94.8% to $0.4 on volume of 100,863,101 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 20.0% to $0.098...